The contribution of founder mutations in BRCA1 to breast cancer in Belarus.

scientific article published in October 2010

The contribution of founder mutations in BRCA1 to breast cancer in Belarus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-0004.2010.01439.X
P698PubMed publication ID20507347
P5875ResearchGate publication ID44634965

P50authorJan LubińskiQ11718282
Cezary CybulskiQ42590472
Steven A. NarodQ50384888
Jacek GronwaldQ91084015
Tadeusz DębniakQ92032189
P2093author name stringO Oszurek
E Savonievich
K Uglanitsa
N Uglanitsa
P433issue4
P921main subjectBelarusQ184
P304page(s)377-380
P577publication date2010-10-01
P1433published inClinical GeneticsQ5133760
P1476titleThe contribution of founder mutations in BRCA1 to breast cancer in Belarus.
P478volume78

Reverse relations

cites work (P2860)
Q37801266BRCA mutations in the management of breast cancer: the state of the art.
Q34185187BRCA1 founder mutations compared to ovarian cancer in Belarus
Q46168959Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations
Q50320232Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland.
Q57112866Genetics of breast cancer in African populations: a literature review
Q35944416Hereditary breast-ovarian cancer syndrome in Russia.
Q31159863Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.
Q35856408Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
Q35830539Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer
Q92832186The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

Search more.